Intended for healthcare professionals

Letters Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes

Authors’ reply to Patel and colleagues

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2927 (Published 24 May 2016) Cite this as: BMJ 2016;353:i2927